Guidelines and Consensus
Brief interpretation of the consensus nomenclature for reporting neovascular age-related macular degeneration data
Yang Yiliu, Yang Tingting, Lu Fang, Li Xiaoxin
Published 2022-02-25
Cite as Chin J Ocul Fundus Dis, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055
Abstract
With the rapid development of fundus imaging technology, it is of great significance to establish a new naming system for neovascular age-related macular degeneration (nAMD) based on the multi-mode imaging. In 2020, an international panel of retina specialists, imaging and image reading center experts, and ocular pathologists reached a consensus after repeated discussions, a new name for nAMD subtype and related lesions was established based on the previous knowledge of fundus fluorescein angiography and pathology, combining indocyanine green angiography, optical coherence tomography and optical coherence tomography angiography with current pathological knowledge, in order to help ophthalmologists to study nAMD. The consensus proposed the term "macular neovascularization" and classified it into type 1, type 2 and type 3. Many lesions related to macular neovascularization, such as pigment epithelial detachment, hemorrhage, fibrosis, rip of retinal pigment epithelium and so on, were named. The new designation will help improve clinical communication between different studies, establish standard definitions and terms between reading centers and researchers, and further promote the understanding and communication of nAMD among ophthalmologists.
Key words:
Wet macular degeneration; Neovascularization, pathologic; Consensus; Interpretation
Contributor Information
Yang Yiliu
Department of Ophthalmology, West China Hospital Sichuan University, Chengdu, 610041, China
Yang Tingting
Editorial Department of Chinese Journal of Ocular Fundus Diseases, West China Hospital Sichuan University, Chengdu, 610041, China
Lu Fang
Department of Ophthalmology, West China Hospital Sichuan University, Chengdu, 610041, China
Li Xiaoxin
Xiamen Ophthalmic Center, Xiamen University, Xiamen 361003, China